Acute lymphoblastic leukaemia trials in Russia
1 of 9 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in RussiaAn Extension Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders
- Where
- Moscow
- Age
- 18 years to 71 years
- People
- 60
- Run by
- National Research Center for Hematology, Russia
See details and how to joinNCT06721598